BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ronan NJ, Elborn JS, Plant BJ. Current and emerging comorbidities in cystic fibrosis. Presse Med 2017;46:e125-38. [PMID: 28554721 DOI: 10.1016/j.lpm.2017.05.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Lehoux Dubois C, Labrèche E, Boudreau V, Colomba J, Mailhot M, Lavoie A, Rabasa-lhoret R, Coriati A. Extra-skeletal impact of vitamin D supplementation protocol in an adult population with cystic fibrosis. Clinical Nutrition 2019;38:1666-71. [DOI: 10.1016/j.clnu.2018.08.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
2 McGlynn JA, Langfelder-Schwind E. Bridging the Gap between Scientific Advancement and Real-World Application: Pediatric Genetic Counseling for Common Syndromes and Single-Gene Disorders. Cold Spring Harb Perspect Med 2020;10:a036640. [PMID: 31570386 DOI: 10.1101/cshperspect.a036640] [Reference Citation Analysis]
3 Reasoner SA, Enriquez KT, Abelson B, Scaglione S, Schneier B, O'Connor MG, Van Horn G, Hadjifrangiskou M. Urinary tract infections in cystic fibrosis patients. J Cyst Fibros 2021:S1569-1993(21)01303-5. [PMID: 34330649 DOI: 10.1016/j.jcf.2021.07.005] [Reference Citation Analysis]
4 Rouzé H, Viprey M, Allemann S, Dima AL, Caillet P, Denis A, Poupon-Bourdy S, Camara B, Llerena C, Reix P, Durieu I, Reynaud Q, Touzet S. Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data. Patient Prefer Adherence 2019;13:1497-510. [PMID: 31564837 DOI: 10.2147/PPA.S211769] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Lafoeste H, Regard L, Martin C, Chassagnon G, Burgel P. Complications aiguës respiratoires et non respiratoires chez l’adulte mucoviscidosique. Revue de Pneumologie Clinique 2018;74:267-78. [DOI: 10.1016/j.pneumo.2018.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Brown R, Nath S, Lora A, Samaha G, Elgamal Z, Kaiser R, Taggart C, Weldon S, Geraghty P. Cathepsin S: investigating an old player in lung disease pathogenesis, comorbidities, and potential therapeutics. Respir Res 2020;21:111. [PMID: 32398133 DOI: 10.1186/s12931-020-01381-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
7 Treps L, Declercq M, Bousfia S, Carmeliet P, Witters P. Comparative meta-analysis of cystic fibrosis cell models suggests partial endothelial-to-mesenchymal transition. J Cyst Fibros 2021:S1569-1993(21)00101-6. [PMID: 33858770 DOI: 10.1016/j.jcf.2021.03.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Dumortier C, Danopoulos S, Velard F, Al Alam D. Bone Cells Differentiation: How CFTR Mutations May Rule the Game of Stem Cells Commitment? Front Cell Dev Biol 2021;9:611921. [PMID: 34026749 DOI: 10.3389/fcell.2021.611921] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Regard L, Martin C, Chassagnon G, Burgel PR. Acute and chronic non-pulmonary complications in adults with cystic fibrosis. Expert Rev Respir Med 2019;13:23-38. [PMID: 30472915 DOI: 10.1080/17476348.2019.1552832] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Filipow N, Davies G, Main E, Sebire NJ, Wallis C, Ratjen F, Stanojevic S. Unsupervised phenotypic clustering for determining clinical status in children with cystic fibrosis. Eur Respir J 2021;58:2002881. [PMID: 33446607 DOI: 10.1183/13993003.02881-2020] [Reference Citation Analysis]
11 Welsner M, Sutharsan S, Taube C, Olivier M, Mellies U, Stehling F. Changes in Clinical Markers During A Short-Term Transfer Program of Adult Cystic Fibrosis Patients from Pediatric to Adult Care. Open Respir Med J 2019;13:11-8. [PMID: 31908684 DOI: 10.2174/1874306401913010011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
12 Gibson HT, McDonald CM, Derrick JW, Eggett DL, Bellini SG. Evaluating Changes in Handgrip Strength in Children With Cystic Fibrosis: A Pilot Study. Nutr Clin Pract 2018;33:261-7. [PMID: 29658185 DOI: 10.1002/ncp.10067] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Lopes-Pacheco M. CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine. Front Pharmacol 2019;10:1662. [PMID: 32153386 DOI: 10.3389/fphar.2019.01662] [Cited by in Crossref: 63] [Cited by in F6Publishing: 56] [Article Influence: 31.5] [Reference Citation Analysis]
14 Pedemonte N. Editorial: Special Issue on "Therapeutic Approaches for Cystic Fibrosis". Int J Mol Sci 2020;21:E6657. [PMID: 32932926 DOI: 10.3390/ijms21186657] [Reference Citation Analysis]
15 Regard L, Lafoeste H, Martin C, Chassagnon G, Burgel PR. [Ageing with cystic fibrosis: Classical and emerging comorbidities in adults with cystic fibrosis]. Rev Pneumol Clin 2018;74:279-91. [PMID: 30316653 DOI: 10.1016/j.pneumo.2018.09.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
16 Woods DF, Flynn S, Caparrós-Martín JA, Stick SM, Reen FJ, O'Gara F. Systems Biology and Bile Acid Signalling in Microbiome-Host Interactions in the Cystic Fibrosis Lung. Antibiotics (Basel) 2021;10:766. [PMID: 34202495 DOI: 10.3390/antibiotics10070766] [Reference Citation Analysis]
17 Caretti A, Peli V, Colombo M, Zulueta A. Lights and Shadows in the Use of Mesenchymal Stem Cells in Lung Inflammation, a Poorly Investigated Topic in Cystic Fibrosis. Cells 2019;9:E20. [PMID: 31861724 DOI: 10.3390/cells9010020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
18 Womack C, Farsin R, Farsad M, Chaudary N. Emerging Alternatives to Conventional Clinic Visits in the Era of COVID-19: Adoption of Telehealth at VCU Adult Cystic Fibrosis Center. Int J Gen Med 2020;13:1175-86. [PMID: 33235489 DOI: 10.2147/IJGM.S274193] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Coffey N, O' Leary F, Burke F, Roberts A, Hayes M. Periodontal and oral health status of people with Cystic Fibrosis: a systematic review. J Dent 2020;103:103509. [PMID: 33129998 DOI: 10.1016/j.jdent.2020.103509] [Reference Citation Analysis]
20 Lai S, Mazzaferro S, Mitterhofer AP, Bonci E, Marotta PG, Pelligra F, Murciano M, Celani C, Troiani P, Cimino G, Palange P. Renal involvement and metabolic alterations in adults patients affected by cystic fibrosis. J Transl Med 2019;17:388. [PMID: 31767021 DOI: 10.1186/s12967-019-02139-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ziyaee F, Dehghani SM, Hosseini S, Zohalinezhad ME, Aleyasin S, Javaherizadeh H. Clinical manifestation, laboratory findings, and outcome of children with cystic fibrosis over a 10-year period in South Iran. Egypt Pediatric Association Gaz 2020;68. [DOI: 10.1186/s43054-020-00045-9] [Reference Citation Analysis]
22 Yadav R, Yoo DG, Kahlenberg JM, Bridges SL Jr, Oni O, Huang H, Stecenko A, Rada B. Systemic levels of anti-PAD4 autoantibodies correlate with airway obstruction in cystic fibrosis. J Cyst Fibros 2019;18:636-45. [PMID: 30638826 DOI: 10.1016/j.jcf.2018.12.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
23 Fonseca C, Bicker J, Alves G, Falcão A, Fortuna A. Cystic fibrosis: Physiopathology and the latest pharmacological treatments. Pharmacol Res 2020;162:105267. [PMID: 33127556 DOI: 10.1016/j.phrs.2020.105267] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
24 Kibbons AM, Peter M, Declercq J, Choi L, Bell J, Jolly J, Cherry E, Alhashemi B, Shah NB, Zuckerman AD. Pharmacist Interventions to Improve Specialty Medication Adherence: Study Protocol for a Randomized Controlled Trial. Drugs - Real World Outcomes 2020;7:295-305. [DOI: 10.1007/s40801-020-00213-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Guo J, He R, Mao ZQ. Case Report: White Colored Stool: An Early Sign of Cystic Fibrosis in Infants. Front Pediatr 2021;9:656584. [PMID: 33937153 DOI: 10.3389/fped.2021.656584] [Reference Citation Analysis]
26 Cordeiro SM, Jesus MCP, Tavares RE, Oliveira DM, Merighi MAB. Experience of adults with cystic fibrosis: a perspective based on social phenomenology. Rev Bras Enferm 2018;71:2891-8. [PMID: 30517390 DOI: 10.1590/0034-7167-2017-0749] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]